FDA approves Fluzakura for treatment of refractory metastatic colorectal cancer

November 9, 2023 2 minute read Add topics to email alerts Receive an email when a new article is posted Enter your email address to receive emails when new articles are posted. . ” data-action=”subscribe”> Subscribe Your request could not be processed. Please try again later. If you continue to experience […]

Evaluation of factors predicting successful outcome in patients scheduled for treatment of acute uncomplicated appendicitis

specialty Please chooseI’m not a medical professional.Allergy and immunologyanatomyanesthesiologyCardiac, thoracic, and vascular surgerycardiologyCritical caredentalDermatologyDiabetes and endocrinologyemergency medical careepidemiology and public healthRegular medicineForensic medicineDepartment of GastroenterologyGeneral medical treatmentgeneticsgeriatricsmedical policyHematologyHIV/AIDShospital-based medical careI’m not a medical professional.InfectionIntegrative medicine/complementary medicineInternal medicineInternal medicine/pediatricsMedical education and simulationmedical physicsmedical studentnephrologyneurosurgeryneurologynuclear medicinenutritionObstetrician and gynecologistoccupational healthoncologyophthalmologyoptometryOral medicineorthopedic surgeryosteopathic medicineOtorhinolaryngologypain managementpalliative carePathologyPediatricspediatric surgeryPhysical therapy and […]

Takeda Pharmaceutical Announces FDA Approval of Colorectal Cancer Treatment

Pharmaceutical company Takeda JP:4502 announced Wednesday that the U.S. Food and Drug Administration has approved Fluzakura for the treatment of certain colorectal cancer patients. Fluzacra (fruquintinib), an oral targeted therapy, has been approved for adults with metastatic colorectal cancer who have received certain prior treatments. of…

CureusBeyond the Horizon: Revealing the Frontiers of Rectal Cancer Research and Treatment Colorectal cancer ranks as one of the most common causes of cancer-related deaths and is a major health threat worldwide. There are growing concerns about the above.

CureusBeyond the Horizon: Revealing the Frontiers of Rectal Cancer Research and Treatment Colorectal cancer ranks as one of the most common causes of cancer-related deaths and is a major health threat worldwide. There are growing concerns about the above.

Help with hemorrhoids: prevention and treatment of recurrence

The best way to prevent hemorrhoids from recurring is to maintain a healthy lifestyle. It is important to prevent constipation. Always make sure your diet includes enough fiber and stay well hydrated to promote healthy bowel movements. If you need help staying hydrated, keep a bottle of water nearby to constantly remind you to drink […]

Cureus Bouldin Treatment Induces Cytotoxicity in Human Colorectal Cancer and Osteosarcoma Cells Introduction Cancer continues to be a major health problem worldwide, and colorectal cancer (CRC) stands out as one of the most important. . …19 hours ago

Cureus Bouldin Treatment Induces Cytotoxicity in Human Colorectal Cancer and Osteosarcoma Cells Introduction Cancer continues to be a major health problem worldwide, and colorectal cancer (CRC) stands out as one of the most important. . …19 hours ago

Bleeding hemorrhoids: treatment etc.

hemorrhoids It occurs when the veins and blood vessels in the anus or lower rectum become swollen and inflamed due to pressure. Approximately 40% of hemorrhoid patients have no symptoms. For symptomatic internal hemorrhoids, the most commonly reported symptom is bleeding. In most cases, hemorrhoids can be treated at home, but more severe cases may […]

Screening and early treatment for anal cancer in people with HIV infection

According to research presented at the conference, people living with HIV who receive topical trichloroacetic acid are about as likely to experience improvement or resolution of precancerous anal cell changes as those who receive electrocautery. patients, but were less likely to experience pain or other side effects. European AIDS Conference (EACS 2023).Another study published in […]